About this trial
The goal of this clinical trial is to learn if the Ultra-Brief Interpersonal Psychotherapy for Adolescents with Suicidal Ideation (IPT-A-SCI) works to reduce suicidal thoughts and behaviors in children and adolescents. The study will also examine whether treatment effects continue after treatment ends and whether some participants benefit more from the intervention than others. The main questions it aims to answer are:
Does IPT-A-SCI reduce suicidal thoughts and behaviors in children and adolescents? Do the effects of IPT-A-SCI continue three months after treatment ends? Do some children and adolescents benefit more from IPT-A-SCI than others?
Participants will:
Receive IPT-A-SCI treatment consisting of five weekly sessions Complete questionnaires before treatment, during treatment, at the end of treatment, and three months after treatment ends Have their parents complete questionnaires at the same time points
Eligibility criteria
Qualifiers
Children and adolescents aged 8-18 years presenting with suicidal ideation or behavior
Suicide risk assessment indicating suitability for outpatient treatment,
Fluency in Hebrew
Ability to attend five weekly treatment sessions
Disqualifiers
Acute medical or psychiatric condition requiring immediate inpatient treatment
Linguistic, developmental, neurological, or intellectual limitations that prevent understanding of the treatment protocol or study procedures
Inability to participate in outpatient psychotherapy
Trial design
Treatments tested in this trial
- IPT-A-SCI
Treatment groups
Sponsors and collaborators
Tel Aviv University
Lead sponsor
Geha Mental Health Center
Collaborator